Immunological issues in clinical composite tissue allotransplantation: Where do we stand today?

Transplantation

Volumn 93, Issue 9, 2012, Pages 855-859

  Morelon, Emmanuel ^a,b   Kanitakis, Jean ^a   Petruzzo, Palmina ^a,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Acute and chronic rejection; Human composite tissue allotransplantation; Immunosuppression; Tolerance

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; COMPLEMENT COMPONENT C4D; GLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; CELL INFILTRATION; CHRONIC GRAFT REJECTION; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE TRANSPLANTATION; TREATMENT RESPONSE;

GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; TISSUE TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84860769966     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31824728b8     Document Type: Review

References (34)

1. Petruzzo P, Lanzetta M, Dubernard JM, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2010; 90: 1590.
2. Murray JE. Organ transplantation (skin, kidney, heart) and plastic surgeon. Plast Reconstr Surg 1971; 47: 425.
3. Lee WP, Yaremchuk MJ, Pan YC, et al. Relative antigenicity of components of vascularized limb allograft. Plast Reconstr Surg 1991; 87: 401.
4. Kanitakis J, Jullien D, Petruzzo P, et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 2003; 76: 688.
5. Landin L, Cavadas P, Nthumba P, et al. Preliminary results of bilateral arm transplantation. Transplantation 2009; 88: 749.
6. Schneeberger S, Kreczy A, Brandacher G, et al. Steroid and ATGresistant rejection after double forearm transplantation responds to Campath 1-H. Am J Transplant 2004; 4: 1372.
7. Kanitakis J, Petruzzo P, Jullien D, et al. Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. Eur J Dermatol 2005; 15: 235.
8. Cendales L, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008; 8: 1396.
9. Kanitakis J, Badet L, Petruzzo P, et al. Clinicopathological monitoring of the skin and oral mucosa of the first human face allograft. Report on the first eight months. Transplantation 2006; 82: 1610.
10. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: A 1-year follow-up study. Lancet 2008; 372: 639.
11. Siemionow M, Papay F, Alam D, et al. First U.S. near-total human face transplantationVA paradigm shift for massive facial injuries. Lancet 2009; 374: 203.
12. Kanitakis J. The challenge of dermatopathological diagnosis of rejection of composite tissue allografts: A review. J Cutan Pathol 2008; 35: 738.
13. El Aljaafari A, Badet L, Kanitakis J, et al. Isolation of regulatory T cells in the skin of a human hand allograft, up to 6 years post-transplantation. Transplantation 2006; 82: 1764.
14. Kanitakis J, McGregor B, Badet L, et al. Absence of C4d deposition in human composite tissue (hands and face) allograft biopsies: An immunoperoxidase study. Transplantation 2007; 84: 65.
15. Landin L, Cavadas PC, Ibañez J, et al. CD3+-mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 2009; 87: 776.
16. Hatz T, Zelger B, Brandacher G, et al. Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts. Transpl Int 2011; 25: 56.
17. Petruzzo P, Kanitakis J, Badet L, et al. Long-term follow-up in composite tissue allotransplantation: In-depth study of five (hand and face) recipients. Am J Transplant 2011; 11: 808.
18. Unadkat JV, Schneeberger S, Goldbach C, et al. Investigation of antibody-mediated rejection in composite tissue allotransplantation in rats. Transplant Proc 2009; 41: 542.
19. Dubernard JM, Lengelé B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007; 357: 2451.
20. Hivelin M, Siemionow M, Grimbert P, et al. Extracorporeal photopheresis: From solid organ to face transplantation. Transpl Immunol 2009; 21: 117.
21. Unadkat JV, Schneeberger S, Horibe EH, et al. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant 2010; 10: 251.
22. Hewitt CW, Black KS, Henson LE, et al. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine. Transplant Proc 1988; 20: 272.
23. Huang WC, Lin JY, Wallace CG, et al. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: An experimental study in rats. Plast Reconstr Surg 2010; 125: 1095.
24. Granger DK, Briedenbach WC, Pidwell DJ, et al. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation 2002; 74: 1624.
25. Kanitakis J, Morelon E, Petruzzo P, et al. Self-renewal capacity of human epidermal Langerhans cells: Observations made on a composite tissue allograft. Exp Dermatol 2011; 20: 145.
26. Kanitakis J, Petruzzo P, Dubernard JM. Turnover of epidermal Langerhans' cells. N Engl J Med 2004; 351: 2661.
27. Ravindra KV, Wu S, Bozulic L, et al. Composite tissue transplantation: A rapidly advancing field. Transplant Proc 2008; 40: 1237.
28. Hautz T, Brandacher G, Zelger B, et al. Indoleamine 2,3-dioxygenase and FoxP3 expression in skin rejection of human hand allografts. Transplant Proc 2009; 41: 509.
29. Schneeberger S, Gorantla VS, van Riet RP, et al. Atypical acute rejection after hand transplantation. Am J Transplant 2008; 8: 688.
30. Gold BG, Yew JY, Zeleny-Pooley M. The immunosuppressant FK506 increases GAP-43 mRNA levels in axotomized sensory neurons. Neurosci Lett 1998; 241: 25.
31. Wood K, Sachs D. Chimerism and transplantation tolerance: Cause and effect. Immunol Today 1996; 64: 427.
32. Elwood ET, Larsen CP, Maurer DH, et al. Microchimerism and rejection in clinical transplantation. Lancet 1997; 349: 1358.
33. Siemionow M, Izycki D, Ozer K, et al. Role of thymus in operational tolerance induction in limb allograft transplant model. Transplantation 2006; 81: 1568.
34. Ramsamooj R, Llull R, Black KS, et al. Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants. Plast Reconstr Surg 1999; 104: 1365.